Chemotherapy drug outperforms remdesivir against SARS-CoV-2 in lab experiments: Study


PTI, Jan 3, 2021, 3:15 PM IST

Beijing: A chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19, according to a study based on computer simulations and lab experiments.

The research, published in the journal PLOS Computational Biology, combined multiple computational techniques that simulate drug-virus interactions from different, complementary perspectives.

Using this hybrid approach, scientists from the Shenzhen Institutes of Advanced Technology in China, screened 1,906 existing drugs for their potential ability to inhibit replication of the novel coronavirus by targeting a viral protein called RNA-dependent RNA polymerase (RdRP).

The researchers identified four promising drugs, which were then tested against the SARS-CoV-2 virus in lab experiments.

They said two of the drugs, pralatrexate and azithromycin, successfully inhibited replication of the virus, and further lab experiments showed that pralatrexate more strongly inhibited viral replication than did remdesivir – a drug that is currently used to treat some COVID-19 patients.

According to the scientists, the findings suggest that pralatrexate could potentially be repurposed to treat COVID-19.

However, the researchers said the chemotherapy drug may prompt significant side effects and is used for people with terminal lymphoma, so they added that immediate use for COVID-19 patients is not guaranteed.

But the research highlighted the importance of the new screening strategy to identify drugs that could be repurposed.

”We have demonstrated the value of our novel hybrid approach that combines deep-learning technologies with more traditional simulations of molecular dynamics,” said study author Haiping Zhang of the Shenzhen Institutes of Advanced Technology.

The researchers are now developing additional computational methods for generating novel molecular structures that could be developed into new drugs to treat COVID-19.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Karnataka HC denies anticipatory bail to Prajwal Revanna in sexual harassment case

Delhi court stays defamation case against CM Atishi

Awards don’t create value for independent films in India: Manoj Bajpayee

Public Alert: Cyber fraudsters impersonating traffic police to demand fines

UP: 25 people booked for attacking civic officials for encroachment removal

SC transfers cheating case against choreographer Remo D’Souza to Delhi court

Fishing vessel collides with naval platform off Goa coast; 2 fishermen missing

Related Articles More

BTS2024: If India can make rocket sensors, it can also make car sensors, says ISRO chief Somanath

World COPD Day: Know your lung function

SpaceX successfully launches ISRO’s 4,700 kg communication satellite from US

As AI and megaplatforms take over, the hyperlinks that built the web may face extinction

Plastic waste could double by 2050, researchers find, suggest policies to address issue

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

BJP stages protest against Congress govt in Karnataka over Waqf properties row

Loyalty Remembered: Mangaluru Airport’s K9 hero Jack passes away

Waqf issue: BJP stages Namma Bhoomi Namma Hakku protest in Bengaluru

Bomb disposal squad tackles ‘security incident’ at UK’s Gatwick Airport

Baba Siddique murder: Man held from Akola, 26th arrest in case

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.